ARIAD Pharmaceuticals, Inc.

Type	Public (NASDAQ: ARIA)
Founded	1991
Headquarters	Cambridge, MA, United States
Key people	Harvey Berger, Chairman & CEO
Industry	Pharmaceuticals
Products	Ridaforolimus (Under development)
Revenue	▲$3.58 million USD (2007)
Operating income	▼$-60.69 million USD (2007)
Net income	▼$-58.52 million USD (2007)
Employees	116 (2007)
Website	www.ariad.com

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) is a small pharmaceutical companies working on cancer drugs. The company is located in Cambridge, Massachusetts. It was established in 1991. It has strong partnerships with Merck.

Contents 1 Products 1.1 Products under development 2 See also 3 References 4 External links

[edit] Products

[edit] Products under development

• Ridaforolimus (formerly Deforolimus)

[edit] See also

• Merck

[edit] References

[edit] External links

• Official ARIAD site

This pharmacology-related article is a stub. You can help Wikipedia by expanding it. v • d • e